Theoretical and Translational Medicine III.
Dr. Lénárt, Ádám
WZU7TJ
Institute of Translational Medicine
06306309988
lenartadam15@gmail.com
The Mechanosensory Transient Receptor Potential Vanilloid 4 Exerts Its Effects Through Prostanoids in the Urinary Bladder
Ádám Lénárt1, Kinga Borsodi1, Helga Balla1, Péter Molnárt József2, Bálint Dér2, Péter Nyirády2, Zoltán Benyó1
1: Institute of Translational Medicine
2: Department of Urology
Szóbeli
Theoretical and Translational Medicine III.
English
Theoretical and Translational Medicine
Overactive bladder syndrome (OAB) is a common urological condition that significantly affects the lives of those affected. The commonly used drugs in treatment have numerous side effects, and their effectiveness often falls short of expectations. The exact pathomechanism of OAB is unknown; however, some theories suggest that dysfunction in the bladder's sensory function may be involved. The Transient Receptor Potential Vanilloid 4 (TRPV4) is an ion channel widely present in the bladder wall, responsible for sensing bladder fullness. Abnormal functioning of TRPV4 may be responsible for altered bladder sensation.
We aim to clarify the signaling pathways of TRPV4-mediated mechanosensation to gain a better understanding of the regulation of micturition and to identify potential novel therapeutic targets for its disorders.
We used 90-120 days old female/male C57Bl/6 and genetically modified [cyclooxygenase-1 knockout (COX-1 KO)] mice. In cystometry, we measured the changes in intravesical pressure during bladder filling. Bladder contractions were measured via myography in isolated mouse bladders. We performed ELISA assays to measure prostanoid levels in bladder samples.
Filling the bladder with a TRPV4 agonist resulted in significant bladder activation, an effect that was inhibited in the presence of intraperitoneally administered indomethacin. In COX-1 KO animals, filling the bladder with the TRPV4 agonist resulted in milder activation compared to wild-type animals. During myography, the TRPV4 agonist induced contractions, an effect that was greatly reduced in the presence of indomethacin. Following TRPV4 agonist treatment, we measured significantly elevated levels of prostaglandin E2 from bladder samples.
Activation of the TRPV4 ion channel causes bladder hyperactivity, an effect primarily mediated by the inflammatory mediator prostaglandin E2. In COX-1 KO animals, the activating effect of TRPV4 did not completely disappear, suggesting that the COX-2 enzyme may also play a role. Activation of TRPV4 induces bladder contractions independent of neural reflexes. By inhibiting the synthesis of prostaglandin E2, we were able to eliminate the bladder-activating effect of TRPV4. Identifying this pathway may provide potential targets for treating voiding disorders.
K-125174,K-135683,K-139230,PD-132851,2020-1.1.6-JÖVŐ-2021-00010,TKP2021-EGA-25,EFOP-3.6.3-VEKOP-16-2017-00009
Semmelweis University
Prof. Dr. Zoltán Benyó
I do not give consent to the publication of my abstract on the website of the congress.
Szabad
elfogadva
szóbeli
nem rendelkezett róla
8254
15:30
15:40